Caprara D - Search Results

1

DNA-GEL, Novel Nanomaterial for Biomedical Applications and Delivery of Bioactive Molecules.

Lattuada E, Leo M, Caprara D, Salvatori L, Stoppacciaro A, Sciortino F, Filetici P. Lattuada E, et al. Among authors: caprara d. Front Pharmacol. 2020 Sep 4;11:01345. doi: 10.3389/fphar.2020.01345. eCollection 2020. Front Pharmacol. 2020. PMID: 33013376 Free PMC article. Review.

2

Hyperbranched DNA clusters.

Lattuada E , Caprara D , Lamberti V , Sciortino F . Lattuada E , et al. Among authors: caprara d. Nanoscale. 2020 Nov 26;12(45):23003-23012. doi: 10.1039/d0nr04840b. Nanoscale. 2020. PMID: 33180079

3

Treatment of kidney clear cell carcinoma, lung adenocarcinoma and glioblastoma cell lines with hydrogels made of DNA nanostars.

Leo M, Lattuada E, Caprara D, Salvatori L, Vecchione A, Sciortino F, Filetici P, Stoppacciaro A. Leo M, et al. Among authors: caprara d. Biomater Sci. 2022 Mar 2;10(5):1304-1316. doi: 10.1039/d1bm01643a. Biomater Sci. 2022. PMID: 35084413

4

Spatially uniform dynamics in equilibrium colloidal gels.

Lattuada E, Caprara D, Piazza R, Sciortino F. Lattuada E, et al. Among authors: caprara d. Sci Adv. 2021 Dec 3;7(49):eabk2360. doi: 10.1126/sciadv.abk2360. Epub 2021 Dec 3. Sci Adv. 2021. PMID: 34860553 Free PMC article.

5

Cold-swappable DNA gels.

Bomboi F , Caprara D , Fernandez-Castanon J , Sciortino F . Bomboi F , et al. Among authors: caprara d. Nanoscale. 2019 May 16;11(19):9691-9697. doi: 10.1039/c9nr01156k. Nanoscale. 2019. PMID: 31066406

6

Exploiting SERS sensitivity to monitor DNA aggregation properties.

Caprara D, Ripanti F, Capocefalo A, Ceccarini M, Petrillo C, Postorino P. Caprara D, et al. Int J Biol Macromol. 2021 Feb 15;170:88-93. doi: 10.1016/j.ijbiomac.2020.12.039. Epub 2020 Dec 29. Int J Biol Macromol. 2021. PMID: 33358955

7

Photonic simulation of entanglement growth and engineering after a spin chain quench.

Pitsios I, Banchi L, Rab AS, Bentivegna M, Caprara D, Crespi A, Spagnolo N, Bose S, Mataloni P, Osellame R, Sciarrino F. Pitsios I, et al. Among authors: caprara d. Nat Commun. 2017 Nov 17;8(1):1569. doi: 10.1038/s41467-017-01589-y. Nat Commun. 2017. PMID: 29146982 Free PMC article.

8

Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.

Siotto M, Simonelli I, Pasqualetti P, Mariani S, Caprara D, Bucossi S, Ventriglia M, Molinario R, Antenucci M, Rongioletti M, Rossini PM, Squitti R. Siotto M, et al. Among authors: caprara d. J Alzheimers Dis. 2016;50(4):1181-9. doi: 10.3233/JAD-150611. J Alzheimers Dis. 2016. PMID: 26836154

9

Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease.

Squitti R, Ghidoni R, Siotto M, Ventriglia M, Benussi L, Paterlini A, Magri M, Binetti G, Cassetta E, Caprara D, Vernieri F, Rossini PM, Pasqualetti P. Squitti R, et al. Among authors: caprara d. Ann Neurol. 2014 Apr;75(4):574-80. doi: 10.1002/ana.24136. Epub 2014 Apr 14. Ann Neurol. 2014. PMID: 24623259

10

Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.

Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page